Director, Head of Translational Sciences

Kata is an immunologist with expertise in autoimmunity. She obtained her doctoral degree from University of Debrecen, Hungary, focused on investigating the fate-decision of activated T cells. Upon completion of her PhD, Kata joined Tibor Glant`s laboratory at Rush University Medical Center in Chicago to work on the proteoglycan-induced arthritis model as a postdoctoral fellow and later as research assistant professor. Kata then moved to Boston to join George Tsokos`s laboratory at Beth Israel Deaconess Medical Center/Harvard Medical School. As an instructor in medicine she contributed to the understanding of dendritic cell – T cell interactions in lupus. In 2016 she accepted a unique opportunity to work on the immunological aspects of hemophilia and related therapies at Biogen. Kata also actively contributed to the establishment of the Biogen spin off company Bioverativ, where she served as immunology group leader and discovered the immunomodulatory effects of recombinant factor VIII Fc fusion protein.

Kata is the author of over 50 original research articles and reviews, and has been an invited reviewer for several international scientific journals.

Kata has a deep appreciation of the complexity of the immune system. She is passionate about translating immunological discoveries into clinical practice.